BIOMAT Database Logo BIOMAT Database Logo

[Formation and persistence of antibodies against envelope antigens of influenza virus after vaccination by formolized monovaccine (author's transl)]. 1978

A Stumpa, and J Bruj, and B Tůmová, and V Skocil

UI MeSH Term Description Entries
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D006389 Hemagglutinins, Viral Specific hemagglutinin subtypes encoded by VIRUSES. Viral Hemagglutinin,Viral Hemagglutinins,Hemagglutinin, Viral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

A Stumpa, and J Bruj, and B Tůmová, and V Skocil
[Formation and persistence of antibodies against antigens of influenza virus envelope after natural infection (author's transl)].
April 1978, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
[Persistence of antibodies after vaccination against measles (author's transl)].
March 1977, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
[Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
January 1982, Trudy Instituta imeni Pastera,
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
[Vaccination against influenza (author's transl)].
January 1979, Annali Sclavo; rivista di microbiologia e di immunologia,
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
[Persistence of antibodies against hepatitis B surface antigens after vaccination against hepatitis B].
February 1985, Deutsche medizinische Wochenschrift (1946),
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
Persistence of antibody to envelope antigens of Heq2Neq2 virus in ponies after infection and vaccination.
July 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
Influenza virus antigens in human leukocytes after oral administration of live tissue culture influenza A monovaccine.
September 1977, Acta virologica,
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination.
July 2007, Influenza and other respiratory viruses,
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
February 1999, Virology,
A Stumpa, and J Bruj, and B Tůmová, and V Skocil
[Neurological complications after influenza vaccination (author's transl)].
May 1977, MMW, Munchener medizinische Wochenschrift,
Copied contents to your clipboard!